
Thursday, December 28, 2023 3:14:06 PM
Recent PROF News
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/07/2025 10:05:34 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/07/2025 09:02:15 PM
- Profound Medical Announces Fourth Quarter and Full Year 2024 Financial Results • GlobeNewswire Inc. • 03/06/2025 09:05:00 PM
- Profound Medical to Release Fourth Quarter and Full Year 2024 Financial Results on March 6 – Conference Call to Follow • GlobeNewswire Inc. • 02/13/2025 10:00:00 PM
- Profound Medical’s Scheduled Presentation at the 43rd Annual J.P. Morgan Healthcare Conference Moved Up to 9:00am PT on January 16th • GlobeNewswire Inc. • 01/13/2025 01:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/08/2025 12:45:33 PM
- Profound Medical Announces Preliminary Unaudited Fourth Quarter and Full Year 2024 Revenues • GlobeNewswire Inc. • 01/08/2025 12:30:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 01/06/2025 01:30:07 PM
- Profound Medical to Present at the 43rd Annual J.P. Morgan Healthcare Conference • GlobeNewswire Inc. • 01/06/2025 01:15:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 12/16/2024 09:05:41 PM
- Profound Medical Announces Closing of US$40.25 Million Underwritten Public Offering of Common Shares • GlobeNewswire Inc. • 12/10/2024 02:55:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 12/06/2024 10:19:49 PM
- Form SUPPL - Voluntary Supplemental Material by Foreign Issuers [Section 11(a)] • Edgar (US Regulatory) • 12/06/2024 10:18:17 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 12/06/2024 08:10:55 PM
- Profound Medical Announces Pricing of US$35 Million Underwritten Public Offering of Common Shares • GlobeNewswire Inc. • 12/06/2024 02:04:58 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 12/05/2024 10:21:23 PM
- Form SUPPL - Voluntary Supplemental Material by Foreign Issuers [Section 11(a)] • Edgar (US Regulatory) • 12/05/2024 10:16:24 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 12/05/2024 10:01:35 PM
- Profound Medical Announces Proposed Public Offering of Common Shares • GlobeNewswire Inc. • 12/05/2024 09:48:14 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 12/02/2024 12:45:04 PM
- Profound Medical and Siemens Healthineers to Offer a Complete Solution for MRI-guided Prostate Therapy • GlobeNewswire Inc. • 12/02/2024 12:30:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 11/26/2024 01:00:17 PM
- Profound Medical to Unveil Next TULSA-AI® Module, ‘UA Alignment Assistant’ • GlobeNewswire Inc. • 11/26/2024 12:45:00 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 11/12/2024 06:52:50 PM
- Profound Medical to Participate in the Stifel 2024 Healthcare Conference • GlobeNewswire Inc. • 11/12/2024 01:00:00 PM
FEATURED Omega Laboratories Reports Completion of Method Validation with Cannabix Technologies Inc. for Marijuana Breath Detection • Mar 18, 2025 8:36 AM
UAV Corp. to Present Critical Inflation Test in 30 Days, Paving the Way to Secure Over $525 Million in DART Series Sales Contracts • UMAV • Mar 14, 2025 1:00 PM
Fifty 1 Labs, Inc. Completes Name and Symbol Change, Advances Toward Regaining 15c211 Compliance • FITY • Mar 14, 2025 10:30 AM
WIN-LIGHT GLOBAL FILES SEC SCHEDULE 13G DISCLOSING 1.96M SHARES OF PASSIVE INSTITUTIONAL INVESTOR OWNERSHIP • CNTM • Mar 14, 2025 7:13 AM
The Crypto Company Expands Leadership Team With Experienced Financial and Blockchain Professionals • CRCW • Mar 13, 2025 9:23 AM
ConnectM Announces $10 Million Share Repurchase Program • CNTM • Mar 13, 2025 9:13 AM